title: Development of new wound dressing composed of spongy collagen sheet containing dibutyryl cyclic AMP.
abstract: Although cyclic AMP has been considered to regulate cell proliferation, the mechanism of this function is largely unknown. Recent studies suggest that cyclic AMP promotes the proliferation of skin cells in a dose-dependent manner. An ointment containing dibutyryl cyclic AMP has been used in the treatment of skin ulcers and found to be effective in promoting tissue repair. To search more efficacious wound management, the authors developed a new wound dressing composed of a spongy atelo-collagen sheet containing dibutyryl cyclic AMP. This wound dressing was evaluated in two types of animal tests. One is the application of the wound dressing to a full-thickness skin defect in order to evaluate the granulation tissue formation and the wound size reduction. The wound dressing was found to promote the granulation tissue formation and naturally reduce the wound size. The other test was the application of the wound dressing to the full-thickness skin defect, leaving behind a skin island in a central portion, in order to evaluate the epithelialization. This skin island left in a full-thickness skin defect was extremely enlarged. The enlargement of the skin island seems to be related to the epithelialization from the margin of the skin island as well as by the expansion of a skin island induced by contraction of the developed granulation tissue in the surrounding wound area. These results suggest that an atelo-collagen spongy sheet containing dibutyryl cyclic AMP is effective in promoting the granulation tissue formation and epithelialization.
authors.affiliation: Department of Plastic and Reconstructive Surgery, School of Medicine, Kitasato University, Kanagawa, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Shibata
authors.forename: N
authors.initials: N
authors.lastname: Shioya
authors.forename: Y
authors.initials: Y
authors.lastname: Kuroyanagi
mesh_terms: D000818:Animals; D001672:Biocompatible Materials; D003994:Bucladesine; D002417:Cattle; D003094:Collagen; D004337:Drug Carriers; D006099:Granuloma / Q000628:therapy; D018919:Neovascularization, Physiologic; D009779:Occlusive Dressings; D051381:Rats; D017207:Rats, Sprague-Dawley; D012867:Skin / Q000098:blood supply / Q000293:injuries; D012871:Skin Diseases / Q000628:therapy; D014945:Wound Healing
chemical_list: D001672:Biocompatible Materials; D004337:Drug Carriers; C059821:atelocollagen; D003994:Bucladesine; D003094:Collagen